Cytokines released in vitro by stromal cells from autologous bone marrow transplant patients with lymphoid malignancy

European Journal of Haematology

Volumn 61, Issue 2, 1998, Pages 100-108

  Roingeard, Françoise ^a   Binet, Christian ^a   Lecron, Jean Claude ^b   Truglio, Danielle ^a   Colombat, Philippe ^a   Domenech, Jorge ^a  

^a CHU BRETONNEAU   (France)

^b CNRS   (France)

Author keywords

Autologous; Cytokines; Long term culture; Stromal cells; Transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 0031831084     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01068.x     Document Type: Article

References (33)

1. MA DDF, VARGA DE, BIGGS JC. Haematopoietic reconstitution after allogenic bone marrow transplantation in man: Recovery of haematopoietic progenitors (CFU-Mix, BFU-E and CFU-GM). Br J Haematol 1987: 65: 5-10.
2. DOMENECH J, LINASSIER C, GIHANA E, et al. Prolonged impairment of hematopoieis after high-dose therapy followed by autologous bone marrow transplantation. Blood 1995: 85: 3320-3327.
3. NOVITZKI N, MOHAMED R. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Exp Hematol 1995: 23: 1661-1666.
4. DEXTER TM, ALLEN TD, LAJTHA LG. Conditions controlling the proliferation of hematopoietic stem cells in vitro. J Cell Physiol 1977: 91: 335-344.
5. GARTNER S, KAPLAN HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 1980: 77: 4756-4759.
6. HOLMBERG LA, SEIDEL K, LEISENRING W, TOROK-STORB B. Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 1994: 84: 3685-3690.
7. KOJIMA S, MATSUYAMA T, KODERA Y. Hematopoietic growth factors released by marrow stromal cells from patients with aplastic anemia. Blood 1992: 79: 2256-2261.
8. LEE M, SEGAL GM, BAGBY GC. Interleukin-1 induces human bone marrow-derived fibroblasts to produce multilineage hematopoietic growth factors. Exp Hematol 1987: 15: 983-988.
9. ROINGFARD F, DOMENECH J, DAYAN A, GIHANA E, COLOMBAT P, BINET C. Cytokine production in long-term marrow cultures after autologous bone marrow transplantation. Bone Marrow Transpl 1995: 15: 741-746.
10. DOMENECH J, GIHANA E, DAYAN A, et al. Haematopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture. Br J Haematol 1994: 88: 488-496.
11. PIKE BL, ROBINSON WA. Human bone marrow colony growth in Agar-gel. J Cell Physiol 1970: 76: 77-84.
12. FALSER AA, MESSNER HA. Granuloerythropoictic colonies in human bone marrow, peripheral blood and cord blood. Blood 1978: 52: 1243-1248.
13. WETZLER M, KURZROCK R, ESTROV Z, ESLEY E, TALPAZ M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leukemia Res 1995: 19: 23-34.
14. HASS R, Wirr B, MÖHLE R. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995: 85: 3754-3761.
15. ARNOLD R, SCHMEISER T, HEIT W, et al. Hematopoietic reconstitution after bone marrow transplantation. Exp Hematol 1986: 14: 271-277.
16. MESSNER HA, CURTIS JE, MINDEN MD, et al. Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 1987: 70: 1425-1432.
17. VERFAILLIE CM. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993: 82: 2045-2053.
18. EAVES CJ, CASHMAN JD, KAY RJ, et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991: 78: 110-117.
19. CASHMAN JD, EAVES AC, RAINES EW, ROSS R, EAVES CJ. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 1990: 75: 96-101.
20. TESTA U, MARTUCCT R, RUTELLA S, et al. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 1994: 84: 3532-3539.
21. RUSCETTI FW, JACOBSEN SEW, BIRCHENALL-ROBERT M. Role of transforming growth factor β in regulation of hematopoiesis. Negative regulators of hematopoiesis. Ann NY Acad Sci 1991: 628: 31-37.
22. CAIRO MS, GILLAN ER, WEINTHAL J, et al. Decreased endogenous circulating steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment. Bone Marrow Transpl 1993: 11: 155-161.
23. WETZLER M, TALPAZ M, LOWE DG, BAIOCCHI G, GUTTERMAN JU, KURXROCK R. Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-α, and TGF-β. Exp Hematol 1991: 19: 347-351.
24. LANFRANCONE L, BORASCHI D, GHIARA P. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-I], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992: 80: 2835-2842.
25. LEARY AG, WONG GG, CLARK SC, SMITH AG, OGAWA M. Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. Blood 1990: 75: 1960-1964.
26. JACOBSEN SEW, KELLER JR, RUSCETTT FW, KONDAIAH P, ROBERTS AB, FALK LA. Bidirectional effects of transforming growth factor β (TGF-β) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-b isoforms. Blood 1991: 78: 2239-2247.
27. BROXMEYER HE, SHERRY B, COOPER S, et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells: interacting effects involving suppression, synergistic suppression and blocking of suppression. J Immunol 1993: 150: 3448-3458.
28. LAGNEAUX L, DELFORGE A, DORVAL C, BRON D, STRYCHMANS P. Excessive production of Transforming growth factor-β by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and Interleukin-6 production. Blood 1993: 82: 2379-2385.
29. KELLER JR, JACOBSEN SEW, SILL KT, ELLINGSWORTH LR, RUSCETTI FW. Stimulation of granulopoiesis by transforming growth factor β: synergy with granulocyte/macrophage-colony-stimulating factor. Proc Natl Acad Sci USA 1991: 88: 7190-7194.
30. HESTDAL K, JACOBSEN SEW, RUSCETTI FW, LONGO DL, BOONE TC, KELLER JR. Increased granulopoiesis after sequential administration of transforming growth factor-β1 and granulocyte-macrophage colony-stimulating factor. Exp Hematol 1993: 21: 799-805.
31. AGLIETTA M, STACCHINI A, SEVERINO A, SANAVIO F, FERRANDO ML, PIACIBELLO W. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Exp Hematol 1989: 17: 296-299.
32. BROXMEYER HE, SHERRY B, LU L, et al. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 1990: 76: 1110-1116.
33. KELLER JR, BARTELMEZ SH, SITNICKA E. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood 1994: 84: 2175-2181.